Voya Investment Management LLC Ligand Pharmaceuticals Inc Transaction History

Voya Investment Management LLC

  • $79.9 Billion
  • Q3 2024

A detailed history of Voya Investment Management LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 5,558 shares of LGND stock, worth $614,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,558
Previous 5,702 2.53%
Holding current value
$614,492
Previous $480,000 15.83%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$82.7 - $110.11 $11,908 - $15,855
-144 Reduced 2.53%
5,558 $556,000
Q2 2024

Dec 03, 2024
BUY
$68.53 - $87.91 $9,868 - $12,659
144 Added 2.59%
5,702 $480,000
Q2 2024

Aug 14, 2024
BUY
$68.53 - $87.91 $5,345 - $6,856
78 Added 1.39%
5,702 $480,000
Q1 2024

Dec 06, 2024
BUY
$68.64 - $89.2 $4,530 - $5,887
66 Added 1.19%
5,624 $411,000
Q1 2024

May 15, 2024
SELL
$68.64 - $89.2 $81,132 - $105,434
-1,182 Reduced 17.37%
5,624 $411,000
Q4 2023

Feb 14, 2024
BUY
$49.57 - $72.63 $3,717 - $5,447
75 Added 1.11%
6,806 $486,000
Q3 2023

Nov 14, 2023
BUY
$58.86 - $72.67 $5,886 - $7,267
100 Added 1.51%
6,731 $403,000
Q2 2023

Aug 14, 2023
BUY
$69.53 - $79.33 $58,683 - $66,954
844 Added 14.58%
6,631 $478,000
Q2 2022

Aug 15, 2022
SELL
$74.52 - $117.06 $15,798 - $24,816
-212 Reduced 3.53%
5,787 $516,000
Q1 2022

May 16, 2022
BUY
$94.99 - $151.56 $10,353 - $16,520
109 Added 1.85%
5,999 $675,000
Q4 2021

Feb 14, 2022
SELL
$127.69 - $165.85 $423,036 - $549,461
-3,313 Reduced 36.0%
5,890 $910,000
Q3 2021

Nov 15, 2021
SELL
$102.33 - $144.73 $10,949 - $15,486
-107 Reduced 1.15%
9,203 $1.28 Million
Q2 2021

Aug 16, 2021
SELL
$113.03 - $155.64 $41,368 - $56,964
-366 Reduced 3.78%
9,310 $1.22 Million
Q1 2021

May 17, 2021
BUY
$99.52 - $215.83 $15,525 - $33,669
156 Added 1.64%
9,676 $1.48 Million
Q4 2020

Feb 16, 2021
BUY
$80.55 - $106.05 $128,235 - $168,831
1,592 Added 20.08%
9,520 $947,000
Q3 2020

Nov 16, 2020
BUY
$89.56 - $126.72 $185,210 - $262,056
2,068 Added 35.29%
7,928 $756,000
Q2 2020

Aug 14, 2020
SELL
$68.28 - $123.65 $190,228 - $344,488
-2,786 Reduced 32.22%
5,860 $655,000
Q1 2020

May 15, 2020
SELL
$63.37 - $107.88 $825,964 - $1.41 Million
-13,034 Reduced 60.12%
8,646 $629,000
Q4 2019

Feb 14, 2020
SELL
$96.94 - $113.59 $2.65 Million - $3.1 Million
-27,317 Reduced 55.75%
21,680 $2.26 Million
Q3 2019

Nov 14, 2019
SELL
$86.25 - $120.16 $14.9 Million - $20.7 Million
-172,441 Reduced 77.87%
48,997 $4.88 Million
Q2 2019

Aug 14, 2019
BUY
$107.38 - $129.34 $1.43 Million - $1.72 Million
13,283 Added 6.38%
221,438 $25.3 Million
Q1 2019

May 15, 2019
BUY
$105.93 - $142.47 $2.06 Million - $2.77 Million
19,425 Added 10.29%
208,155 $26.2 Million
Q4 2018

Feb 14, 2019
BUY
$128.36 - $272.13 $5.15 Million - $10.9 Million
40,133 Added 27.01%
188,730 $25.6 Million
Q3 2018

Nov 14, 2018
BUY
$211.18 - $274.49 $205,055 - $266,529
971 Added 0.66%
148,597 $40.8 Million
Q2 2018

Aug 14, 2018
SELL
$150.77 - $207.98 $47,341 - $65,305
-314 Reduced 0.21%
147,626 $30.6 Million
Q1 2018

May 15, 2018
BUY
$138.63 - $182.62 $18.5 Million - $24.4 Million
133,793 Added 945.73%
147,940 $24.4 Million
Q4 2017

Feb 14, 2018
SELL
$128.36 - $147.04 $19,125 - $21,908
-149 Reduced 1.04%
14,147 $1.94 Million
Q3 2017

Nov 14, 2017
BUY
$120.91 - $137.94 $1.73 Million - $1.97 Million
14,296
14,296 $1.95 Million

Others Institutions Holding LGND

# of Institutions
255
Shares Held
18.1M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.87B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email